Unicycive Therapeutics (UNCY) Common Equity (2020 - 2026)
Unicycive Therapeutics (UNCY) reported Common Equity of $53.27 million for Q2 2026, up 224.2% from $16.43 million a year earlier and up 41.3% from the prior quarter.
Powered by 
Analysis
Unicycive Therapeutics (UNCY) Common Equity (2020 - 2026) Analysis & Trends
At the end of FY2025, Unicycive Therapeutics posted Common Equity of $30.2 million, up 306.4% from FY2024.
- By year, Common Equity came in at $7.43 million in FY2024, -$3.81 million in FY2023, -$466,000 in FY2022 and $16.48 million in FY2021.
- The Q2 2026 figure ranks as the highest quarterly Common Equity in data going back to Q2 2020.
- Year over year, Common Equity has now increased in each of the last three quarters.
- Per Business Quant data, the three quarters before Q2 2026 came in at $37.7 million (Q1 2026), $30.2 million (Q4 2025) and $37.48 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 33.88 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 84.97 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | -5.94 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 41.98 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 11.83 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 85.49 Bn |
| 10 | Unicycive Therapeutics | 104.17 Mn | -95.81 Mn | - | 53.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 53.27 Mn |
| Mar 31, 2026 | 37.70 Mn |
| Dec 31, 2025 | 30.20 Mn |
| Sep 30, 2025 | 37.48 Mn |
| Jun 30, 2025 | 16.43 Mn |
| Mar 31, 2025 | 11.27 Mn |
| Dec 31, 2024 | 7.43 Mn |
| Sep 30, 2024 | -27.85 Mn |
| Jun 30, 2024 | -14.85 Mn |
| Mar 31, 2024 | -24.46 Mn |
| Dec 31, 2023 | -3.81 Mn |
| Sep 30, 2023 | 3.43 Mn |
| Jun 30, 2023 | -19.37 Mn |
| Mar 31, 2023 | -15.08 Mn |
| Dec 31, 2022 | -466,000.00 |
| Sep 30, 2022 | 4.63 Mn |
| Jun 30, 2022 | 9.91 Mn |
| Mar 31, 2022 | 13.24 Mn |
| Dec 31, 2021 | 16.48 Mn |
| Sep 30, 2021 | 19.00 Mn |
API Access
Unicycive Therapeutics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=UNCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "UNCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=UNCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();